Status:
COMPLETED
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Familial Adenomatous Polyposis
Eligibility:
All Genders
Brief Summary
This study reviews post study clinical endoscopy reports in follow up to patients who participated in MAY2016-07-01 with weekly erlotinib for familial adenomatous polyposis. Reviewing follow up medica...
Detailed Description
PRIMARY OBJECTIVE: I. To review clinical endoscopy reports, pathology reports, and other medical records related to standard-of-care endoscopic evaluations for all participants in the parent study, M...
Eligibility Criteria
Inclusion
- MAY2016-07-01 study participants for whom medical records are available and accessible
Exclusion
- MAY2016-07-01 study participants who have opted out of medical records reviews or for whom consent for medical record review cannot be confirmed/documented
Key Trial Info
Start Date :
May 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 17 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04674228
Start Date
May 7 2021
End Date
May 17 2022
Last Update
June 16 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
2
M D Anderson Cancer Center
Houston, Texas, United States, 77030